Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Satellos Bioscience Inc
T.MSCL
Alternate Symbol(s):
MSCLF
Healthcare
Biotechnology
Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and...
regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MSCL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
(7)
•••
london6ers
X
View Profile
View Bullboard History
Comment by
london6ers
on Jul 25, 2023 12:53pm
RE:RE:RE:Ranked #1
I agree but lots of the muscle is filled by scar tissue. What does this do? Replace scar tissue with functioning muscle cells? That's crazy if true..
(3140)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on May 23, 2023 1:41pm
RE:RE:Ranked #1
This will be a 25 bagger if that small molecule drug with the potential to regenerate functional muscle is successful as it will have many advantages and benefits for patients muscular
...more
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource
posted Sep 19, 2024 9:00am by
Northstar Gold Corp.
-
|
The MOU grants Hunan Nonferrous the opportunity to explore and develop a near-surface NI43-101 gold mineral resource at Northstar’s 100%-owned Miller Copper-Gold Property, located 18 kilometers southeast of Kirkland Lake, Ontario. This will be achieved by diamond drilling up to 10,000 meters, allowing Hunan Nonferrous to earn a negotiated interest in the resultant NI43-101 gold resource. ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 17, 2023 5:29pm
New Press Release - Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
Toronto, Ontario--(Newsfile Corp. - May 17, 2023) - Bloom Burton & Co. Inc. announces that, today, it and its affiliate acquired 1,453,070 common shares (Shares) and 6,636,734 compensation options (Compensation Options) of Satellos Bioscience Inc. (Corporation) in connection with a public...
read article.
(90)
•••
G1945V
X
View Profile
View Bullboard History
Post by
G1945V
on May 17, 2023 9:43am
Satellos closes $55M Financing
Satellos Bioscience Closes $55M Financing to Support Development of its Lead Drug Candidate for Duchenne Muscular Dystrophy G1945V
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 19, 2023 10:46am
New Press Release - IIROC Trading Resumption - MSCL
VANCOUVER, BC, April 19, 2023 /CNW/ - Trading resumes in:Company: Satellos Bioscience Inc.TSX-Venture Symbol: MSCLAll Issues: YesResumption (ET): 11:00 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 19, 2023 10:26am
New Press Release - Satellos Bioscience Inc. Announces Pricing of Public Offering
Toronto, Ontario--(Newsfile Corp. - April 19, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, is pleased to announce the pricing and terms of...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 19, 2023 9:29am
New Press Release - IIROC Trading Halt - MSCL
VANCOUVER, BC, April 19, 2023 /CNW/ - The following issues have been halted by IIROC:Company: Satellos Bioscience Inc.TSX-Venture Symbol: MSCLAll Issues: YesReason: Pending NewsHalt Time (ET): 9:17 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 18, 2023 5:18pm
New Press Release - Satellos Bioscience Inc. Announces Public Offering of Common Shares
Toronto, Ontario--(Newsfile Corp. - April 18, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, announced today that it has filed a preliminary...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 30, 2023 9:57pm
New Press Release - Satellos Bioscience Announces 2022 Year End Financial Results and Operational Highlights
Toronto, Ontario--(Newsfile Corp. - March 30, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) ("Satellos" or the "Company"), a drug discovery company developing small molecule therapeutics to regenerate muscle as a new approach to treating disease conditions from muscular dystrophy...
read article.
(0)
•••
Flatlander05
X
View Profile
View Bullboard History
Comment by
Flatlander05
on Mar 30, 2023 4:11pm
RE:RE:Ranked #1
100%
(2)
•••
trumpmaster
X
View Profile
View Bullboard History
Comment by
trumpmaster
on Mar 30, 2023 4:05pm
RE:Ranked #1
Good article. Would be nice to see MSCL market cap in the 100's of millions like number 2 and 3 on the list. That would make my day!! :)
(0)
•••
Flatlander05
X
View Profile
View Bullboard History
Post by
Flatlander05
on Mar 30, 2023 4:01pm
Ranked #1
https://investingnews.com/daily/life-science-investing/biotech-investing/top-canadian-biotech-stocks/
(2)
•••
trumpmaster
X
View Profile
View Bullboard History
Post by
trumpmaster
on Mar 30, 2023 3:36pm
Miss the boat
Judging by the number of posts here, alot of people are going to miss the boat in this one. great couple of months here and and hope more ahead.. Good Trading Trump
(37)
•••
bmreed
X
View Profile
View Bullboard History
Post by
bmreed
on Mar 14, 2023 2:46pm
Business Update: CTO Phil Lambert Discusses SAT-3153 Results
Business Update: Satellos Bioscience $MSCL with CTO Philip Lambert - https://youtu.be/OZAfLhS9WB4 Chief Technology Officer Phil Lambert Discusses SAT-3153 Study Results
...more
(90)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Feb 17, 2023 1:09pm
RE:Zacks-Fireside Chat With Frank Gleeson-02/13/2023
Zacks - Small-Cap Research - Outlook - David Bautz PhD https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_02072023_MSCLF_Bautz.pdf G1945V
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed
EnviroGold Global Announces Appointment of Chief Operating Officer